OpenURL Connection Search

Select item for more details and to access through your institution.

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
Published in:
BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12336-0
By:
- Janssen, J. C.;
- van Dijk, B.;
- de Joode, K.;
- Aarts, M. J. B.;
- van den Berkmortel, F. W. P. J.;
- Blank, C. U.;
- Boers-Sonderen, M. J.;
- van den Eertwegh, A. J. M.;
- de Groot, J. W. B.;
- Jalving, M.;
- de Jonge, M. J. A.;
- Joosse, A.;
- Kapiteijn, E.;
- Kamphuis-Huismans, A. M.;
- Naipal, K. A. T.;
- Piersma, D.;
- Rikhof, B.;
- Westgeest, H. M.;
- Vreugdenhil, G.;
- Oomen-de Hoop, E.
Publication type:
Article
Effect of rIFN-γ on Antibody-Mediated Cytotoxicity via Human Monocyte IgG Fc Receptor II (CD32).
Published in:
Scandinavian Journal of Immunology, 1992, v. 36, n. 3, p. 385, doi. 10.1111/j.1365-3083.1992.tb02952.x
By:
- van Schie, R. C. A. A.;
- Verstraten, H. G. G.;
- Tax, W. J. M.;
- van den Berkmortel, F. W. P. J.;
- van de Winkel, J. G. J.;
- de Mulder, P. H. M.
Publication type:
Article
Progressive arterial wall stiffening in patients with increasing diastolic blood pressure.
Published in:
Journal of Human Hypertension, 2001, v. 15, n. 10, p. 685, doi. 10.1038/sj.jhh.1001245
By:
- van den Berkmortel, F W P J;
- van der Steen, M;
- Hoogenboom, H;
- Wollersheim, H;
- van Langen, H;
- Thien, Th
Publication type:
Article
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
Published in:
2021
By:
- Mulder, E. E. A. P.;
- de Joode, K.;
- Litière, S.;
- ten Tije, A. J.;
- Suijkerbuijk, K. P. M.;
- Boers-Sonderen, M. J.;
- Hospers, G. A. P.;
- de Groot, J. W. B.;
- van den Eertwegh, A. J. M.;
- Aarts, M. J. B.;
- Piersma, D.;
- van Rijn, R. S.;
- Kapiteijn, E.;
- Vreugdenhil, G.;
- van den Berkmortel, F. W. P. J.;
- Hoop, E. Oomen-de;
- Franken, M. G.;
- Ryll, B.;
- Rutkowski, P.;
- Sleijfer, S.
Publication type:
journal article
Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation.
Published in:
European Journal of Clinical Investigation, 2000, v. 30, n. 11, p. 972, doi. 10.1046/j.1365-2362.2000.00739.x
By:
- van den Berkmortel, F. W. P. J.;
- Demacker, P. N. M.;
- Wollersheim, H.;
- Thien, T.;
- Stalenhoef, A. F. H.
Publication type:
Article
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort.
Published in:
Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 15, doi. 10.1111/pcmr.13117
By:
- Borgers, J. S. W.;
- Burgers, F. H.;
- Schina, A.;
- Van Not, O. J.;
- van den Eertwegh, A. J. M.;
- Blank, C. U.;
- Aarts, M. J. B.;
- van den Berkmortel, F. W. P. J.;
- de Groot, J. W. B.;
- Hospers, G. A. P.;
- Kapiteijn, E.;
- Piersma, D.;
- van Rijn, R. S.;
- Boer, A. M. Stevense‐den;
- van der Veldt, A. A. M.;
- Vreugdenhil, G.;
- Boers‐Sonderen, M. J.;
- Wouters, M. W. J. M.;
- Suijkerbuijk, K. P. M.;
- van Thienen, J. V.
Publication type:
Article

Found: 6

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.

Effect of rIFN-γ on Antibody-Mediated Cytotoxicity via Human Monocyte IgG Fc Receptor II (CD32).

Progressive arterial wall stiffening in patients with increasing diastolic blood pressure.

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.

Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation.

Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort.